Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 166 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1651 5.4 months metastatic breast cancer 4 Biologic therapy
Cleveland Clinic Brain Tumor Institute United States 1/2006
Treatment Details: Patients: This Phase III study involved 515 patients of whom 397 had brain metastases from advanced non-small-cell lung cancer or breast cancer. The patients were divided into two groups, w
 
1652 5.4 months Advanced NSCLC 5 Biologic therapy
Lineberger Comprehensive Cancer Center United States 2/2008
Treatment Details: Patients: This phase II study involved 63 patients with advanced non-small-cell lung cancer. The median age was 60, ranging from 33 to 86 years old. Sixteen percent of the patients had ne
 
1653 5.4 months Advanced NSCLC 4 Chemotherapy
Consorcio Hospital General Universitario de Valencia Spain 3/2006
Treatment Details: Patients: This Phase III study involved a total of 254 patients. Patients were divided into two groups: Group A had 129 patients and Group B had 125 patients. The median age for patients i
 
1654 5.3 months Metastatic colorectal cancer 4 Chemotherapy
Korea University Medical Center Korea 3/2011
Treatment Details: Patients: This study involved 20 patients with metastatic colorectal cancer whose disease had progressed following previous FOLFOX and FOLFIRI chemotherapy regimens. Treatment: Patients
 
1655 5.3 months Advanced or metastatic NSCLC 5 Biologic therapy
University of Iowa United States 4/2005
Treatment Details: Patients: This Phase II study involved 22 patients with advanced NSCLC. Eighteen of the patients were men, and four were women. The median age was 65 years. All patients had previously re
 
1656 5.3 months Recurrent GBM 4 Chemotherapy
University of Wisconsin United States 4/2002
Treatment Details: Patients: This Phase II study involved 45 patients with recurrent gliomas. Thirty-four patients had glioblastoma multiforme. Treatment: The treatment consisted of two drugs, carboplatin
 
1657 5.3 months Metastatic colorectal carcinoma 3 Biologic therapy
Chemotherapy
Vejle Hospital Denmark 6/2013
Treatment Details: Patients: This phase 2 study involved 64 previously treated patients with KRAS-mutant metastatic colorectal cancer. The median patient age was 62 years and 56% were male. Treatment: Pa
 
1658 5.3 months Advanced NSCLC 3 Biologic therapy
Maastricht University Medical Center Netherlands 2/2013
Treatment Details: Patients: This phase 2 study involved 57 advanced non-small cell lung cancer patients who had previously been treated with platinum-based chemotherapy. Their cancer was classified as havin
 
1659 5.2 months Locally advanced metastatic breast cancer 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 5/2009
Treatment Details: Patients: This phase 2 study involved 69 women with locally advanced metastatic breast cancer. Their average (mean) age was 53 years, ranging from 30 to 83. There were two groups of patien
 
1660 5.2 months Advanced NSCLC 3 Chemotherapy
Yonsei University College of Medicine Korea 6/2007
Treatment Details: Patients: This phase II study involved 21 patients with stage IIIB/IV recurrent or metastatic non-small-cell lung cancer. All had received prior chemotherapy including gefitinib. The medi
 
Page 166 of 187  | Previous Page  | Next Page